Lin, Jialing
Pearson, Sallie-Anne
Greenfield, Jerry R.
Park, Kyeong Hye
Havard, Alys
Brieger, David
Day, Richard O.
Falster, Michael O.
de Oliveira Costa, Juliana
Funding for this research was provided by:
NHMRC Medicines Intelligence Centre of Research Excellence (1196900, 1196900)
National Health and Medical Research Council (NHMRC) Ideas Grants (2002889)
National Heart Foundation of Australia (105609)
University of New South Wales
Article History
Received: 7 June 2023
Accepted: 7 July 2023
First Online: 14 July 2023
Declarations
:
: The New South Wales Population and Health Services Research Ethics Committee approved the study (2019/ETH01176) and the Services Australia External Request Evaluation Committee granted data access (RMS2613).
: Not applicable.
: SAP is a member of the Drug Utilisation Sub Committee of the Pharmaceutical Benefits Advisory Committee. The views expressed in this paper do not represent those of the Committee.